The DOI matches its Crossref record.
IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide.
Abstract
Mast cells produce a number of cytokines including IL-6. In view of the large amounts of de novo synthesis induced by the activation of rat peritoneal mast cells and previous observations of expression of this cytokine by human lung mast cells, we have studied the regulation of IL-6 production. We examined the hypothesis that mast cell IL-6 production is not related to previous histamine release. Highly purified rat peritoneal mast cells were activated with anti-IgE, calcium ionophore A23187, or LPS. Histamine was used as a marker of preformed mediator release and IL-6 production was assessed by using the B9 hybridoma growth factor bioassay. Anti-IgE activation of rat peritoneal mast cells induced IL-6 production and histamine release. In contrast, LPS activation induced substantial, serum-dependent, IL-6 production without a significant level of histamine release. No preformed IL-6 was detected in the cells. Calcium ionophore induced histamine release from mast cells to a greater extent than did anti-IgE, but no A23187-induced IL-6 production was observed. A23187-treated cells retained high viability and produced a significant amount of TNF-alpha. To further examine the concordance of IL-6 production and histamine release we used mast cell stabilizing drugs. Dexamethasone and nedocromil significantly inhibited IL-6 production in response to anti-IgE. Our results demonstrate that there is not a direct relationship between mast cell degranulation and IL-6 production. Our observations are important for understanding the role of mast cells in inflammation and for developing strategies to modulate mast cell function in disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances
Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. M., & Tsai, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141025 · Cited by 1,017
Critical protective role of mast cells in a model of acute septic peritonitis
Echtenacher, B., Männel, D. N., & Hültner, L. (1996) · Nature · doi:10.1038/381075a0 · Cited by 926
Mast-cell responses to pathogens
Marshall, J. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1460 · Cited by 861
Self-citationMast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Mast Cell Function: A New Vision of an Old Cell
da Silva, E. Z. M., Jamur, M. C., & Oliver, C. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414545334 · Cited by 604
Galli, S. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00007 · Cited by 521
Interleukin-6 in the Injured Patient: Marker of Injury or Mediator of Inflammation?
Biffl, W. L., Moore, E. E., Moore, F. A., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 502
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 472
Critical role of mast cells in inflammatory diseases and the effect of acute stress
Theoharides, T. C., & Cochrane, D. E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.041 · Cited by 436
Differential release of mast cell mediators and the pathogenesis of inflammation
Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P., & Kalogeromitros, D. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00519.x · Cited by 425
Kalesnikoff, J., Huber, M., Lam, V., Damen, J. E., Zhang, J., Siraganian, R. P., & Krystal, G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00159-5 · Cited by 412
Mast cells as sentinels of innate immunity
Galli, S. J., Maurer, M., & Lantz, C. S. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80010-7 · Cited by 381
Supajatura, V., Ushio, H., Nakao, A., Okumura, K., Ra, C., & Ogawa, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2250 · Cited by 370
McCurdy, J. D., Olynych, T. J., Maher, L. H., & Marshall, J. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1625 · Cited by 349
Self-citationThe Critical Role of Mast Cells in Allergy and Inflammation
THEOHARIDES, T. C., & KALOGEROMITROS, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.025 · Cited by 291
Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells
Varadaradjalou, S., Féger, F., Thieblemont, N., Hamouda, N. B., Pleau, J., Dy, M., & Arock, M. (2003) · European Journal of Immunology · doi:10.1002/eji.200323830 · Cited by 291
Impaired mast cell-dependent natural immunity in complement C3-deficient mice
Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J., & Carroll, M. C. (1997) · Nature · doi:10.1038/36586 · Cited by 277
Mast cell involvement in interstitial cystitis: a review of human and experimental evidence
Theoharides, T. C., Kempuraj, D., & Sant, G. R. (2001) · Urology · doi:10.1016/s0090-4295(01)01129-3 · Cited by 275
The role of mast cells in migraine pathophysiology
Theoharides, T. C., Donelan, J., Kandere-Grzybowska, K., & Konstantinidou, A. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.11.006 · Cited by 264
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., & Rose, N. R. (2004) · Autoimmunity · doi:10.1080/0891693042000196200 · Cited by 115
“have been found to release IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IFN-g, and TGF-b as well as other mediators of inflammation.([25,63]) Recently the percentage of degranulating MCs has been shown to directly correlate with the onset of disease in an acute model of MS([24]) as well as acute and chronic RA.”
BackgroundMast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
“Human umbilical cord-derived mast cells (hCBMCs) primed with IL-4 or IL-5 before stimulation with IgE release more TNF, IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF), compared to hCBMCs maintained in SCF alone.”
BackgroundInfluentialCoelho, A.-M., Fioramonti, J., & Buéno, L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.4.g781 · Cited by 63
Sewell, W. A., Scurr, L. L., Orphanides, H., Kinder, S., & Ludowyke, R. I. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.1.18-23.1998 · Cited by 56
TGF-β1 Limits the Onset of Innate Lung Inflammation by Promoting Mast Cell–Derived IL-6
Ganeshan, K., Johnston, L. K., & Bryce, P. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203362 · Cited by 45
Papadopoulou, N. G., Oleson, L., Kempuraj, D., Donelan, J., Cetrulo, C. L., & Theoharides, T. C. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01833 · Cited by 30
Metadata
- Authors
- Leal-Berumen, I., Conlon, P., & Marshall, J. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-06-01
- Volume
- 152
- Issue
- 11
- Pages
- 5468-5476
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1622558337
- Cited by
- 204
- References
- 0
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.